ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 929,51
0,30%
DAX
17 932,17
-1,10%
Brent Oil
83,61
-2,66%
Bitcoin
56 968,62
-5,99%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cerevel Therapeutics Holdings Inc (CERE)

  7. Cerevel Therapeutics Holdings Inc (CERE) Actualités

CERE Cerevel Therapeutics Holdings Inc

42,61
-0,10 (-0,23%)
Dernière mise à jour : 18:30:18
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cerevel Therapeutics Holdings Inc CERE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,10 -0,23% 42,61 18:30:18
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
42,73 42,60 42,86 42,71
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
18/4/202412:30GLOBECerevel Therapeutics Announces Positive Topline Results for..
27/2/202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
16/2/202422:46EDGAR2Form 8-K - Current report
09/2/202415:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
09/2/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202414:30PRNUSKuehn Law Encourages MDC, WAVD, NS and CERE Investors to..
23/1/202423:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/1/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202413:44EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
18/1/202413:19EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
05/1/202423:13EDGAR2Form PREM14A - Preliminary proxy statements relating to..
03/1/202400:10PRNUSKuehn Law Encourages CERE, HA, IMGN, and WAVD Investors to..
28/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/12/202323:03EDGAR2Form 144 - Report of proposed sale of securities
22/12/202302:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202302:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202322:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202322:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/12/202323:00EDGAR2Form SC 13D/A - General statement of acquisition of..
08/12/202312:23IHMARKETNEWSApple Boosts Vietnam Production, Broadcom Revenue Miss,..
08/12/202301:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202322:32EDGAR2Form 144 - Report of proposed sale of securities
07/12/202322:31EDGAR2Form 144 - Report of proposed sale of securities
07/12/202314:02EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/12/202314:00EDGAR2Form 8-K - Current report
07/12/202312:23IHMARKETNEWSAlphabet Unveils Advanced AI Model, AMD Expects $45 Billion..
07/12/202305:24PRNUSCERE MERGER ANNOUNCEMENT: Julie & Holleman LLP Announces..
06/12/202322:30PRNUSAbbVie to Acquire Cerevel Therapeutics in Transformative..
06/12/202300:42EDGAR2Form 144 - Report of proposed sale of securities
29/11/202312:30GLOBECerevel Therapeutics to Host Investor Webcast on Tavapadon..
08/11/202312:30GLOBECerevel Therapeutics to Present at Upcoming Investor..
01/11/202311:39EDGAR2Form 8-K - Current report
01/11/202311:30GLOBECerevel Therapeutics Reports Third Quarter 2023 Financial..
18/10/202322:32EDGAR2Form SC 13D/A - General statement of acquisition of..
13/10/202312:30GLOBECerevel Therapeutics to Report Third Quarter 2023 Financial..
12/10/202322:19EDGAR2Form 8-K - Current report
12/10/202322:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/10/202304:45GLOBECerevel Therapeutics Announces Pricing of $450 Million..
11/10/202322:14EDGAR2Form 8-K - Current report
11/10/202322:08EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/10/202322:01GLOBECerevel Therapeutics Announces Proposed Public Offering of..

Dernières Valeurs Consultées

NASDAQ
CERE
Cerevel Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés